sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
substanti
morbid
mortal
delet
envelop
e
protein
modestli
diminish
viru
growth
tissu
cultur
abrog
virul
anim
show
immun
delet
accessori
protein
addit
e
nearli
complet
protect
balbc
mice
fatal
respiratori
diseas
caus
mouseadapt
sarscov
partli
protect
tg
mice
lethal
diseas
tg
mice
express
human
sarscov
receptor
extrem
suscept
infect
also
show
induc
antiviru
cell
antibodi
respons
edelet
virus
stabl
blind
passag
tissu
cultur
cell
singl
mutat
surfac
glycoprotein
detect
passag
viru
remain
avirul
mice
result
suggest
efficaci
vaccin
candid
might
use
sar
recur
sever
acut
respiratori
syndrom
caus
novel
coronaviru
sarscov
infect
individu
approxim
mortal
rate
peiri
et
al
diseas
recur
signific
extent
sinc
coronavirus
similar
one
caus
epidem
continu
circul
wild
anim
especi
bat
popul
woo
et
al
sar
epidem
spark
effort
develop
vaccin
would
use
futur
outbreak
sar
occur
inactiv
live
attenu
vaccin
describ
thu
far
earli
stage
develop
initi
studi
sever
salient
observ
emerg
first
transfer
neutral
antibodi
direct
surfac
glycoprotein
prior
infect
complet
protect
experiment
infect
anim
clinic
diseas
greenough
et
al
rockx
et
al
subbarao
et
al
zhu
et
al
second
sarscov
vaccin
effect
young
age
anim
popul
term
protect
clinic
diseas
develop
neutral
antibodi
respons
deme
et
al
third
precis
viral
protein
includ
particular
vaccin
import
consider
vaccin
includ
nucleocapsid
n
protein
result
immunopatholog
pulmonari
diseas
character
eosinophil
infiltr
sarscovchalleng
mice
deme
et
al
yasui
et
al
gener
live
attenu
vaccin
offer
protect
subsequ
challeng
virul
viru
induc
humor
tcellmedi
immun
respons
live
attenu
coronaviru
vaccin
develop
coronaviru
pathogen
infecti
bronchiti
viru
transmiss
gastroenter
viru
saif
addit
issu
must
consid
develop
sarscov
vaccin
viru
like
origin
sarslik
cov
infect
bat
lau
et
al
li
et
al
viru
jump
speci
infect
intermedi
host
himalayan
palm
civet
wet
market
southern
china
prior
infect
human
chines
therefor
ideal
vaccin
also
efficaci
zoonot
strain
sarscov
therebi
minim
likelihood
viru
suffici
time
adapt
human
popul
sarscov
like
coronavirus
rna
viru
replic
cytoplasm
virion
envelop
contain
least
three
structur
protein
e
embed
membran
also
like
coronavirus
sarscov
encod
sever
groupspecif
protein
term
snijder
et
al
protein
essenti
replic
tissu
cultur
cell
delet
significantli
attenu
viru
growth
mice
dediego
et
al
yount
et
al
contrast
delet
small
envelop
e
protein
modestli
reduc
sarscov
growth
vitro
vivo
dediego
et
al
dediego
et
al
result
attenu
viru
coronavirus
delet
e
result
either
complet
absenc
infecti
viru
sever
reduct
titer
kuo
master
ortego
et
al
howev
e
delet
context
sarscov
result
decreas
viru
titer
tissu
cultur
cell
dediego
et
al
sarscov
infect
replic
sever
speci
includ
mice
ferret
hamster
nonhuman
primat
anim
develop
inappar
mild
diseas
review
subbarao
robert
mice
transgen
tg
express
human
sarscov
receptor
angiotensinconvert
enzym
obtain
mccray
et
al
tseng
et
al
mice
develop
moder
respiratori
diseas
overwhelm
neurolog
diseas
mortal
intranas
infect
sarscov
use
assess
vaccin
safeti
efficaci
previous
show
infect
highli
suscept
mice
recombin
sarscov
delet
e
e
sever
groupspecif
protein
gene
result
weight
loss
death
even
inocul
plaqu
form
unit
pfu
contrast
mice
infect
pfu
either
rsarscov
rsarscov
delet
groupspecif
gene
rsarscov
succumb
infect
dediego
et
al
result
suggest
potenti
safe
vaccin
stabil
efficaci
immunogen
examin
initi
studi
addit
evalu
context
sever
pulmonari
infect
import
manifest
diseas
infect
human
recent
isol
sarscov
adapt
growth
mice
rat
nagata
et
al
nagata
et
al
robert
et
al
provid
use
system
vaccin
evalu
strain
mice
rat
infect
virus
develop
sever
respiratori
diseas
specif
strain
isol
passag
lung
balbc
mice
unlik
parent
urbani
strain
viru
intranas
inocul
viru
result
sign
respiratori
diseas
substanti
mortal
use
infect
system
assess
protect
abil
context
respiratori
diseas
also
determin
antibodi
cell
respons
balbc
tg
mice
infect
result
immun
protect
mice
respiratori
diseas
balbc
mice
intranas
inocul
balbc
mice
viru
result
clinic
evid
respiratori
diseas
dosag
approxim
pfu
result
mortal
rate
zhao
et
al
use
challeng
dosag
pfu
caus
mortal
substanti
weight
loss
fig
triangl
experi
describ
next
show
infect
pfu
caus
weight
loss
mortal
balbc
mice
fig
b
expect
dosag
viru
caus
diseas
tg
mice
extrem
suscept
infect
urbani
strain
sarscov
assess
protect
abil
virus
infect
viru
balbc
mice
immun
pfu
challeng
day
later
pfu
viru
fig
follow
challeng
mice
immun
delet
mutant
exhibit
weight
loss
day
pi
immun
mice
recov
surviv
contrast
mice
challeng
dose
viru
lost
significantli
weight
mice
succumb
infect
day
pi
determin
effect
immun
viru
growth
titer
lung
immun
mice
measur
day
postchalleng
immun
result
sixweekold
balbc
mice
infect
pfu
circl
n
squar
n
monitor
daili
surviv
weight
loss
b
c
sixweekold
balbc
mice
immun
pfu
circl
n
squar
n
phosphatebuff
salin
pb
triangl
n
challeng
day
postinfect
pfu
viru
surviv
c
weight
loss
record
daili
differ
surviv
statist
signific
p
b
reduct
viru
titer
lung
day
pi
respect
fig
viru
caus
patholog
chang
consist
pneumonia
includ
alveolar
edema
alveolar
slough
necrot
bronchiol
interstiti
perivascular
inflammatori
cell
infiltr
fig
e
vaccin
result
substanti
diminut
extent
patholog
chang
challeng
mice
littl
evid
lung
destruct
inflammatori
cell
infiltr
present
fig
c
result
show
singl
dose
abl
protect
mice
clinic
diseas
prevent
lung
damag
decreas
viru
replic
immun
partial
protect
tg
mice
challeng
urbani
strain
describ
tg
mice
exquisit
sensit
infect
wildtyp
sarscov
ld
approxim
pfu
dediego
et
al
mccray
et
al
sever
diseas
occur
viru
gain
entri
brain
via
olfactori
nerv
effect
immun
respons
would
like
need
prevent
entri
nearli
viru
brain
sinc
brain
viru
spread
rapid
widespread
netland
et
al
next
examin
protect
mediat
immun
challeng
pfu
urbani
strain
singl
immun
either
protect
approxim
mice
death
challeng
pfu
urbani
strain
sarscov
fig
assess
whether
viru
titer
brain
correl
protect
analyz
four
addit
anim
one
asymptomat
viru
detect
brain
symptomat
mice
averag
geometr
titer
brain
fourth
mice
experi
averag
geometr
titer
brain
pbstreat
mice
develop
sever
diseas
note
pfu
equival
approxim
ld
even
overwhelm
infect
vaccin
show
efficaci
sinc
complet
partli
protect
virusinfect
balbc
sarscov
urbani
straininfect
tg
mice
next
sought
determin
immun
correl
protect
previou
report
show
passiv
administr
neutral
antibodi
direct
protein
could
prevent
infect
greenough
et
al
rockx
et
al
subbarao
et
al
zhu
et
al
initi
determin
antisarscov
antibodi
titer
elisa
neutral
assay
day
immun
prior
challeng
urbani
strain
sarscov
elisa
mice
mount
detect
antibodi
respons
whole
inactiv
viru
tabl
respons
approxim
lower
balbc
compar
tg
mice
pool
sampl
n
vs
n
p
b
antibodi
titer
higher
tg
mice
immun
compar
immun
anim
although
differ
reach
statist
signific
p
neutral
antibodi
titer
sera
immun
balbc
mice
measur
neutral
antibodi
detect
eight
mice
low
titer
titer
also
measur
neutral
titer
use
sera
separ
group
tg
mice
immun
mice
mice
detect
low
level
antibodi
sera
titer
immun
mice
role
sarscovspecif
cell
viru
clearanc
directli
demonstr
patient
import
cell
viru
erad
mice
infect
anoth
genu
coronaviru
mous
hepat
viru
mhv
shown
previous
bergmann
lane
stohlman
thu
like
cell
critic
viru
clearanc
infect
human
experiment
anim
therefor
measur
sarscovspecif
cell
respons
blood
balbc
tg
mice
day
immun
urbani
strain
viru
respect
spleen
day
pi
intracellular
releas
assay
sever
cell
epitop
recogn
brestrict
balbc
restrict
mice
report
zhao
et
al
zhi
et
al
use
lung
mononuclear
cell
harvest
lung
balbc
mice
recent
confirm
ident
mani
epitop
also
identifi
addit
epitop
zhao
et
al
detect
sarscovspecif
respons
seven
one
cell
epitop
lung
infect
mice
purpos
assess
efficaci
immun
tg
mice
measur
respons
blood
two
immunodomin
cell
epitop
span
residu
surfac
glycoprotein
respons
epitop
detect
blood
tg
mice
day
pi
spleen
mice
sacrif
day
pi
fig
respons
higher
mice
immun
differ
respons
epitop
nearli
reach
statist
signific
blood
day
vs
n
vs
n
p
fig
spleen
day
n
vs
n
p
fig
three
immunodomin
cell
epitop
encompass
residu
spike
glycoprotein
one
cell
epitop
identifi
use
lung
mononuclear
cell
harvest
virusinfect
balbc
mice
zhao
et
al
assay
describ
measur
cell
respons
immunodomin
epitop
cell
respons
less
robust
detect
tg
mice
cell
respons
detect
blood
infect
mice
day
pi
mean
respons
detect
cell
respons
similar
detect
tg
mice
respect
fig
could
detect
sarscovspecif
cell
respons
spleen
immun
mice
day
pi
could
detect
cell
respons
blood
day
spleen
day
immun
balbc
mice
cell
stimul
peptid
correspond
epitop
data
shown
collect
result
show
induc
cell
respons
balbc
tg
mice
key
featur
live
attenu
vaccin
must
stabl
passag
tissu
cultur
cell
crucial
anim
human
especi
true
sarscov
rapidli
underw
adapt
replic
intermedi
host
palm
civet
human
popul
sarscov
may
continu
adapt
human
popul
epidem
termin
effici
rapidli
address
stabil
serial
passag
virus
time
vero
cell
passag
virus
replic
effici
vitro
titer
approxim
higher
passag
virus
fig
determin
basi
increas
abil
replic
vero
cell
sequenc
complet
genom
passag
virus
remark
singl
mutat
posit
result
serin
phenylalanin
mutat
detect
passag
time
viru
tabl
mutat
locat
outsid
receptor
bind
domain
protein
also
detect
e
passag
time
vero
cell
mutat
common
virus
tissu
cultur
passag
one
present
like
respons
improv
replic
cell
addit
mutat
also
detect
signific
mutat
locat
primas
gene
unknown
adapt
occur
rapidli
protein
mutat
detect
within
passag
vero
cell
tabl
determin
still
attenu
vivo
inocul
tg
mice
pfu
viru
remain
attenu
minim
mortal
respect
weight
loss
fig
b
sinc
virus
grew
higher
titer
tissu
cultur
cell
next
determin
abil
protect
tg
mice
challeng
wildtyp
viru
alter
passag
immun
tg
mice
challeng
intranas
inocul
pfu
urbani
strain
sarscov
protect
mice
protect
suggest
tissu
cultur
passag
diminish
immunogen
fact
may
mediat
increas
protect
fig
show
two
attenu
virus
serv
effect
vaccin
prevent
sarscovinduc
respiratori
diseas
fig
may
ultim
use
vaccin
candid
absenc
groupspecif
protein
addit
e
make
less
like
wildtyp
viru
regener
recombin
although
equal
attenu
initi
studi
dediego
et
al
expect
would
equival
immunogen
groupspecif
protein
role
inhibit
type
ifn
signal
orf
apoptosi
induct
e
orf
orf
chen
et
al
frieman
et
al
khan
et
al
kopeckybromberg
et
al
lai
et
al
law
et
al
schaecher
mackenzi
pekosz
tan
et
al
yang
et
al
ye
et
al
therefor
delet
protein
might
predict
modul
immunogen
occur
signific
extent
although
may
induc
slightli
higher
humor
cell
respons
sarscovspecif
cell
antibodi
respons
detect
vaccin
tg
balbc
mice
fig
present
precis
role
respons
viru
clearanc
patient
sar
well
defin
patient
recov
mount
good
virusspecif
antibodi
respons
wherea
develop
sever
diseas
cameron
et
al
base
studi
coronaviru
infect
like
virusspecif
cell
antibodi
respons
critic
viru
clearanc
mice
infect
mhv
cell
respons
necessari
viru
clearanc
acut
phase
infect
wherea
antimhv
antibodi
necessari
prevent
viru
recrudesc
bergmann
lane
stohlman
passiv
administr
neutral
antibodi
prior
sarscov
infect
complet
prevent
diseas
hamster
wildtyp
tg
mice
greenough
et
al
mccray
et
al
robert
et
al
rockx
et
al
subbarao
et
al
zhu
et
al
immun
result
antivir
antibodi
respons
measur
elisa
day
pi
tabl
although
neutral
antibodi
titer
low
consist
result
virusspecif
antibodi
titer
mice
infect
mhv
measur
elisa
reach
maximum
day
pi
neutral
titer
detect
day
pi
reach
peak
valu
day
pi
tschen
et
al
futur
goal
determin
whether
kinet
develop
neutral
antibodi
follow
pattern
mhv
whether
protect
long
last
result
also
show
tissu
cultur
adapt
result
viru
immunogen
one
tg
mous
die
infect
greater
percentag
mice
challeng
rsarscov
surviv
compar
immun
unpassag
viru
fig
note
gain
virul
rel
minor
sinc
ld
sarscov
tg
mice
pfu
tg
mice
die
infect
pfu
evid
increas
virul
observ
balbc
mice
consist
extrem
suscept
infect
exhibit
tg
mice
tissu
cultur
adapt
virus
often
result
gener
virus
attenu
anim
howev
sarscov
state
activ
adapt
palm
civet
intermedi
host
human
epidem
termin
chines
kan
et
al
song
et
al
thu
may
surpris
viru
underw
adapt
tissu
cultur
cell
passag
singl
mutat
detect
protein
although
region
respons
bind
host
cell
receptor
wong
et
al
develop
vaccin
requir
addit
passag
vero
human
tissu
cultur
cell
determin
viru
continu
undergo
adapt
primat
cell
possibl
gain
loss
virul
immunogen
potenti
gain
virul
indic
import
introduc
addit
mutat
viru
ensur
safeti
one
obviou
candid
mutat
sinc
protein
involv
modul
host
immun
respons
kamitani
et
al
narayanan
et
al
zust
et
al
mutat
mhv
shown
attenu
viru
without
affect
immunogen
base
similar
sarscov
mhv
mutat
predict
similar
effect
sar
epidem
age
popul
risk
develop
sever
diseas
peiri
guan
yuen
age
mice
like
human
year
age
suscept
sarscov
mount
effect
immun
respons
sarscov
immunogen
effect
younger
popul
deme
et
al
import
determin
safe
efficaci
popul
collect
data
describ
suggest
use
vaccin
candid
vaccin
safe
protect
challeng
sarscov
two
rodent
infect
induc
cell
antibodi
respons
evid
immunopatholog
diseas
balbc
lung
detect
immun
either
viru
challeng
virul
viru
human
angiotensinconvert
enzym
transgen
mice
b
restrict
gener
previous
describ
mccray
et
al
pathogenfre
balbc
mice
purchas
nation
cancer
institut
anim
studi
approv
univers
iowa
anim
care
use
committe
ksiazek
center
diseas
control
atlanta
ga
mouseadapt
strain
sarscov
gener
provid
k
subbarao
nih
recombin
strain
sarscov
rsarscov
gener
previous
describ
dediego
et
al
dediego
et
al
viru
propag
titer
determin
vero
cell
atcc
manassa
va
mice
lightli
anesthet
isofluran
viru
administ
intranas
dulbecco
modifi
eagl
medium
mice
immun
intranas
pfu
recombin
virus
unpassag
passag
challeng
experi
tg
mice
inocul
pfu
wildtyp
sarscov
balbc
mice
inocul
pfu
intranas
sarscov
work
perform
univers
iowa
laboratori
core
facil
anim
anaesthet
transcardi
profus
phosphatebuff
salin
follow
zinc
formalin
lung
inflat
zinc
formalin
remov
fix
overnight
zinc
formalin
paraffin
embed
section
stain
hematoxylin
eosin
whole
blood
collect
immun
mice
day
postinfect
sera
prepar
elisa
titer
perform
follow
maxisorp
immuno
plate
nunc
coat
pfu
formaldehyd
uvinactiv
sarscov
bei
sixweekold
tg
mice
inocul
pfu
circl
n
squar
n
wildtyp
rsarscov
triangl
n
monitor
daili
surviv
weight
loss
b
differ
surviv
statist
signific
p
b
c
sixweekold
tg
mice
immun
pfu
circl
n
squar
n
pb
triangl
n
challeng
day
postimmun
pfu
sarscov
urbani
surviv
c
weight
loss
record
daili
resourc
manassa
va
wash
well
expos
threefold
dilut
sera
immun
mice
h
well
wash
treat
sequenti
dilut
peroxidaseconjug
protein
biorad
hercul
ca
h
tetramethylbenzidin
kblue
max
tmb
substrat
neogen
corpor
lexington
ky
min
room
temperatur
reaction
stop
h
absorb
read
nm
elisa
titer
defin
highest
dilut
serum
give
twofold
increas
background
viru
plaqu
reduct
assay
use
determin
serum
neutral
antibodi
titer
sera
dilut
indic
ratio
incub
pfu
sarscov
min
plaqu
assay
perform
previous
describ
dediego
et
al
virusspecif
cell
measur
intracellular
cytokin
stain
ic
incub
brefeldin
bd
pharmingen
san
diego
ca
presenc
absenc
sarscov
peptid
tg
mice
b
restrict
peptid
correspond
two
previous
identifi
cell
epitop
encompass
residu
protein
use
zhi
et
al
balbc
mice
peptid
correspond
previous
identifi
cell
epitop
encompass
residu
protein
cell
epitop
contain
residu
n
protein
use
zhao
et
al
zhi
et
al
measur
cell
respons
blood
cell
coat
peptid
prior
brefeldin
incub
cell
stain
fluorescein
isothiocyan
fitc
conjug
anti
mab
allophycocyanin
apc
conjug
mab
bd
pharmingen
describ
previous
wu
et
al
gener
passag
virus
viral
stock
initi
inocul
onto
confluent
vero
cell
seed
cm
flask
one
third
viral
supernat
infect
cell
serial
passag
time
onto
fresh
cell
h
postinfect
hr
pi
passag
virus
titer
vitro
growth
kinet
vero
cell
cm
flask
inocul
passag
viru
multipl
infect
moi
absorpt
h
inoculum
remov
ml
fresh
medium
ad
supernat
infect
cell
titer
hr
pi
total
rna
infect
vero
cell
isol
use
rneasi
mini
kit
qiagen
hilden
germani
trizol
invitrogen
carlsbad
ca
two
microgram
rna
revers
transcrib
previous
describ
pew
et
al
seri
overlap
pcr
product
cover
entir
sarscov
genom
gener
use
amplitaq
polymeras
appli
biosystem
pcr
product
sequenc
use
forward
revers
primer
use
gener
product
appli
biosystem
model
dna
sequenc
mutat
confirm
use
least
two
independ
deriv
sampl
infect
cell
rna
student
test
use
analyz
differ
mean
valu
group
result
express
mean
standard
error
mean
sem
p
valu
consid
statist
signific
